B
Bruce L. Miller
Researcher at University of California, San Francisco
Publications - 1296
Citations - 135366
Bruce L. Miller is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Frontotemporal dementia & Dementia. The author has an hindex of 163, co-authored 1153 publications receiving 115975 citations. Previous affiliations of Bruce L. Miller include University of Southern California & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
TDP-43 frontotemporal lobar degeneration and autoimmune disease
Zachary A. Miller,Katherine P. Rankin,Neill R. Graff-Radford,Leonel T. Takada,Leonel T. Takada,Virginia E. Sturm,Clare M. Cleveland,Lindsey A. Criswell,Philipp A. Jaeger,Trisha Stan,Kristin Heggeli,Sandy Chan Hsu,Sandy Chan Hsu,Anna Karydas,Baber K. Khan,Lea T. Grinberg,Maria Luisa Gorno-Tempini,Adam L. Boxer,Howard J. Rosen,Joel H. Kramer,Giovanni Coppola,Giovanni Coppola,Daniel H. Geschwind,Daniel H. Geschwind,Rosa Rademakers,William W. Seeley,Tony Wyss-Coray,Bruce L. Miller +27 more
TL;DR: Findings suggest a unique pattern of systemic inflammation in svPPA and PGRN and open new research avenues for understanding and treating disorders associated with underlying transactive response DNA-binding protein 43 aggregation.
Journal ArticleDOI
Do tests of executive functioning predict ability to downregulate emotions spontaneously and when instructed to suppress
Anett Gyurak,Madeleine S. Goodkind,Anita Madan,Joel H. Kramer,Bruce L. Miller,Robert W. Levenson +5 more
TL;DR: Of four commonly used measures of EF, verbal fluency best indexes the complex processes of monitoring, evaluation, and control necessary for successful emotion regulation, both spontaneously and following instructions to suppress.
Journal ArticleDOI
Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease
Michael D. Geschwind,Amy Kuo,Katherine Wong,Aissa Haman,Gillian Devereux,Benjamin J. Raudabaugh,David Y. Johnson,Charles C. Torres-Chae,Ron Finley,Paul A. Garcia,Julie N. Thai,Hugo Quinny Cheng,John Neuhaus,Sven Forner,Jacque L. Duncan,Katherine L. Possin,Stephen J. DeArmond,Stanley B. Prusiner,Bruce L. Miller +18 more
TL;DR: This interventional study provides Class I evidence that quinacrine does not improve survival for people with sCJD when given orally at a dose of 300 mg per day for 2 months, and shows that double-blinded, placebo-controlled, randomized treatment trials are possible in prion disease.
Journal ArticleDOI
Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus
Antao Du,Norbert Schuff,Norbert Schuff,Mikko P. Laakso,Xiaoping Zhu,William J. Jagust,Kristine Yaffe,Joel H. Kramer,Bruce L. Miller,Bruce R Reed,David Norman,Helena C. Chui,Michael Weiner,Michael Weiner +13 more
TL;DR: The entorhinal cortex and hippocampus are less affected by subcortical ischemic vascular dementia than by AD and adding global cerebral changes to hippocampus substantially improved the classification.
Journal ArticleDOI
The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: Part I.
John R. Hodges,Bruce L. Miller +1 more
TL;DR: This review argues for the retention of the term FTD as the general clinical label, with further subcategorization into the three principal clinical syndromes seen at presentation: frontal variant FTD (often called dementia of frontal type), semantic dementia and progressive non-fluent aphasia.